Source: StreetInsider

Press Release: Alcresta : Alcresta Therapeutics Announces Preclinical Data Showing ALC-078 Cartridge Use in SBS Model Associated with Reduced Dependence on Parenteral Nutrition

Results published in Annals of Surgery highlight potential applications of Alcresta's ALC-078 cartridge in short bowel syndrome nutrition management WALTHAM, Mass., March 16,...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Daniel Orlando's photo - Chairman & CEO of Alcresta

Chairman & CEO

Daniel Orlando

CEO Approval Rating

90/100

Read more